Videos

Mindera Health | George Mahaffey, CEO

Mindera's SkinAtlas is a scalable platform that leverages artificial intelligence and machine learning to analyze patient-specific data collected from a dermal biomarker patch.

True Digital Surgery | September Riharb

True Digital Surgery develops next-generation solutions for the operating room. The company's flagship system, Occipta, is a heads-up, digital mircoscope and imaging platform intended to improve surgeons' control and visualization capabilities during reconstructive surgery.

Potrero Medical | Joe Urban, CEO

A predictive health company developing the next generation of medical devices with smart sensors and artificial intelligence.

CoapTech | Howard Carolan, CEO

CoapTech has developed a minimally invasive ultrasound for use in creating gastrostomies. The PUMA-G system is FDA-cleared to guide enteral feeding tube placement at the bedside.

Alio | David Kuraguntla, CEO

Alio's SmartPatch is a discrete patch that continuously monitors and tracks vitals, including O2 saturation, temperature, blood pressure, and more.

Miracor Medical | Olivier Delporte, CEO

Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO). A novel first-line therapy used during PCI to positively change the course for Acute MI patients.

Deep Blue Medical Advances | Bill Perry, CEO

Surgeon-invented T-Line® Hernia Mesh with integral suture-like extensions designed to eliminate a key point of failure for conventional mesh fixation - the mesh, suture, tissue interface - and to provide superior anchor strength.

Galen Robotics | Bruce Lichorowic, President & CEO

Digital-Surgery-as-a-Service (DSaaS) combining the power of a new microsurgery platform with a system of big data analytics and machine learning to provide advanced surgical assistance in performing delicate or intricate procedures.

Levita Magnetics | Alberto Rodriguez-Navarro, CEO

Levita Magnetics' innovative magnetic surgical platform, called Magnetic Surgery®, is the next step in the evolution of less invasive surgery.

Carevature | Dennis Farrell, President & CEO

Carevature Medical develops advanced orthopedic solutions to address limitations of current surgical solutions.

restor3d | Ken Gall, CEO

By combining expertise in 3D printing with advanced biomaterials and artificial intelligence, restor3d is creating patient-specific orthopedic implants to reconstruct and repair the human body.

Retia Medical | Marc Zemel, CEO

Retia makes advanced hemodynamic monitors using the patented Multi-Beat Analysis MBA™ algorithm to guide care for high-risk surgical and ICU patients.

Leonhardt Ventures | Howard Leonhardt, CEO

The company is focused on organ regeneration & recovery innovations based on the convergence of bioelectrics & biologics.

Roundtable Keynote: A View from All Sides of the Medtech Innovation Table

A lively discussion to explore lessons learned and opportunities ahead.

Lucid Diagnostics | Lishan Aklog, Chairman

Lucid is developing solutions to help clinicians diagnose and manage the progression of esophageal disease.

Dymicron | Ted Bird, Chief Strategy Officer

Dymicron is an innovation-driven medical technology company that is advancing a new generation of musculoskeletal devices made from Polycrystalline Diamond (PCD), one of the strongest substances known to man, and a material for which Dymicron has exclusive patented use in all human interbody applications.

Vicarious Surgical | Adam Sachs, CEO

Transforming surgery through robotics and virtual reality. The Vicarious Surgical robot will offer surgeons a 360 degree view and reach within the patient and surgical field.

TibaRay | Jeff Amacker, CEO

TibaRay is developing a next-generation radiation therapy technology, called PHASER, to deliver radiation treatment with unprecedented accuracy and exquisite shaping by ultrafast imaging.

Nanochon | Ben Holmes, CEO

Nanochon is applying novel materials to replicate bone and cartilage, and high-end 3D printing to create an implant which can permanently repair debilitating joint injuries.

OYE Therapeutics | Brett Dines, CEO

OYE (Open Your Eyes) Therapeutic's intervention is set to remove over $5.5B in annual avoidable costs from US hospitals and surgery centers by solving the defined problem of delayed operating room turnover due to extended emergence time from anesthesia.